NASDAQ:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis $1.32 -0.20 (-12.83%) As of 02:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About IM Cannabis Stock (NASDAQ:IMCC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IM Cannabis alerts:Sign Up Key Stats Today's Range$1.31▼$1.5350-Day Range$1.51▼$2.3352-Week Range$1.33▼$8.10Volume6,299 shsAverage Volume84,057 shsMarket Capitalization$2.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.Read More… Remove Ads IM Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks22nd Percentile Overall ScoreIMCC MarketRank™: IM Cannabis scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for IM Cannabis. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of IM Cannabis is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IM Cannabis is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIM Cannabis has a P/B Ratio of 0.29. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about IM Cannabis' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.26% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IM Cannabis has recently decreased by 38.75%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIM Cannabis does not currently pay a dividend.Dividend GrowthIM Cannabis does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.26% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IM Cannabis has recently decreased by 38.75%, indicating that investor sentiment is improving significantly. News and Social Media3.1 / 5News Sentiment0.63 News SentimentIM Cannabis has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for IM Cannabis this week, compared to 0 articles on an average week.Search Interest9 people have searched for IMCC on MarketBeat in the last 30 days. This is an increase of 800% compared to the previous 30 days.MarketBeat Follows1 people have added IM Cannabis to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IM Cannabis insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.91% of the stock of IM Cannabis is held by insiders.Percentage Held by InstitutionsOnly 7.68% of the stock of IM Cannabis is held by institutions.Read more about IM Cannabis' insider trading history. Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address IMCC Stock News HeadlinesIM Cannabis Corp. (IMCC) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comIM Cannabis Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 31, 2025 | prnewswire.comTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 4, 2025 | Porter & Company (Ad)IM Cannabis (IMCC) Projected to Post Quarterly Earnings on MondayMarch 29, 2025 | americanbankingnews.comIM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ETMarch 20, 2025 | prnewswire.comIM Cannabis Announces Change of AuditorsJanuary 17, 2025 | prnewswire.comIM Cannabis Corp Raises Funds Amid Global ChallengesDecember 5, 2024 | markets.businessinsider.comIM Cannabis Corp. (IMCC) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comSee More Headlines IMCC Stock Analysis - Frequently Asked Questions How have IMCC shares performed this year? IM Cannabis' stock was trading at $2.33 at the beginning of 2025. Since then, IMCC stock has decreased by 43.1% and is now trading at $1.3250. View the best growth stocks for 2025 here. How were IM Cannabis' earnings last quarter? IM Cannabis Corp. (NASDAQ:IMCC) announced its quarterly earnings results on Monday, March, 31st. The company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.39) by $0.16. The firm had revenue of $9.27 million for the quarter, compared to analysts' expectations of $14.48 million. IM Cannabis had a negative net margin of 25.55% and a negative trailing twelve-month return on equity of 129.86%. When did IM Cannabis' stock split? IM Cannabis's stock reverse split on Friday, July 12th 2024. The 1-6 reverse split was announced on Friday, July 12th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IM Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that IM Cannabis investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), General Electric (GE) and AppLovin (APP). Company Calendar Last Earnings3/31/2025Today4/04/2025Next Earnings (Estimated)5/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:IMCC CIK1792030 Webwww.imcannabis.com Phone972-54-433-1111FaxN/AEmployees340Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,040,000.00 Net Margins-25.55% Pretax Margin-29.52% Return on Equity-129.86% Return on Assets-23.63% Debt Debt-to-Equity Ratio0.10 Current Ratio0.70 Quick Ratio0.59 Sales & Book Value Annual Sales$51.39 million Price / Sales0.07 Cash FlowN/A Price / Cash FlowN/A Book Value$4.55 per share Price / Book0.33Miscellaneous Outstanding Shares2,232,000Free Float2,100,000Market Cap$3.39 million OptionableNot Optionable Beta1.03 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:IMCC) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredThe bigger story behind the recent market pullbackNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.